![Wolfgang Wurst](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wolfgang Wurst
Corporate Officer/Principal chez
Technische Universität München
Profil
Wolfgang Wurst is the founder of Affectis Pharmaceuticals AG, which was founded in 2004.
He held the title of Director-Supervisory Board.
Currently, he is a Professor at Technische Universität München and the Head-Molecular Neurogenetics Group at Helmholtz Zentrum München.
In the past, he worked as the Leader-Molecular Neurogenetics at Max-Planck Institute of Psychiatry.
Dr. Wurst received his undergraduate degree from the University of Freiburg and his doctorate from the University of Gottingen.
Postes actifs de Wolfgang Wurst
| Sociétés | Poste | Début |
|---|---|---|
Technische Universität München
 Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Helmholtz Zentrum München Deutsches Forschungszentrum
 Helmholtz Zentrum München Deutsches Forschungszentrum Miscellaneous Commercial ServicesCommercial Services Provides health research services | Corporate Officer/Principal | - |
Anciens postes connus de Wolfgang Wurst
| Sociétés | Poste | Fin |
|---|---|---|
Max-Planck Institute of Psychiatry
 Max-Planck Institute of Psychiatry The Max Planck Institute of Psychiatry is an interdisciplinary research and clinical center focused on understanding the causes of psychiatric disorders, particularly stress-related conditions such as depression, anxiety, and psychosis. The company is based in Munich, Germany. The institute integrates basic science, clinical research, and patient care to develop improved, personalized diagnostic methods, therapies, and preventive strategies. It operates a research hospital offering outpatient, day, and inpatient services, where scientific findings are translated into clinical practice. Research areas include genetics, neurobiology, emotion research, psychophysiology, and precision psychiatry, with studies on immune system dysregulation, circadian rhythms, and AI models predicting treatment-related risks. The institute fosters collaboration among clinicians and scientists and provides career and training opportunities, including international PhD programs, integrated doctoral and residency programs, and participation in graduate schools. Educational outreach includes seminars, public lectures, and practical training for medical students. The institute also engages in historical reflection regarding its past involvement in unethical practices and undertakes projects to honor victims and promote remembrance. | Corporate Officer/Principal | - |
Affectis Pharmaceuticals AG
 Affectis Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of neurodegenerative and neuroinflammatory diseases | Fondateur | - |
Formation de Wolfgang Wurst
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
19
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
University of Freiburg
 University of Freiburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Technische Universität München
Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Affectis Pharmaceuticals AG
Affectis Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of neurodegenerative and neuroinflammatory diseases | Health Technology |
University of Gottingen
 University of Gottingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Max-Planck Institute of Psychiatry
Max-Planck Institute of Psychiatry The Max Planck Institute of Psychiatry is an interdisciplinary research and clinical center focused on understanding the causes of psychiatric disorders, particularly stress-related conditions such as depression, anxiety, and psychosis. The company is based in Munich, Germany. The institute integrates basic science, clinical research, and patient care to develop improved, personalized diagnostic methods, therapies, and preventive strategies. It operates a research hospital offering outpatient, day, and inpatient services, where scientific findings are translated into clinical practice. Research areas include genetics, neurobiology, emotion research, psychophysiology, and precision psychiatry, with studies on immune system dysregulation, circadian rhythms, and AI models predicting treatment-related risks. The institute fosters collaboration among clinicians and scientists and provides career and training opportunities, including international PhD programs, integrated doctoral and residency programs, and participation in graduate schools. Educational outreach includes seminars, public lectures, and practical training for medical students. The institute also engages in historical reflection regarding its past involvement in unethical practices and undertakes projects to honor victims and promote remembrance. | |
Helmholtz Zentrum München Deutsches Forschungszentrum
Helmholtz Zentrum München Deutsches Forschungszentrum Miscellaneous Commercial ServicesCommercial Services Provides health research services | Commercial Services |
